Xianhuo Wang

4.2k total citations
101 papers, 3.0k citations indexed

About

Xianhuo Wang is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xianhuo Wang has authored 101 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 39 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Xianhuo Wang's work include Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (14 papers). Xianhuo Wang is often cited by papers focused on Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (14 papers). Xianhuo Wang collaborates with scholars based in China, United States and Sweden. Xianhuo Wang's co-authors include Yuquan Wei, Lijuan Chen, Huilai Zhang, Maling Gou, Yujie Wei, Shiyong Zhou, Xingyi Li, Lihua Qiu, Zhengzi Qian and Xinyu Zhao and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Xianhuo Wang

95 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianhuo Wang China 30 1.0k 697 417 387 368 101 3.0k
Mehdi Dadashpour Iran 38 1.3k 1.2× 915 1.3× 297 0.7× 693 1.8× 174 0.5× 77 3.2k
Ling Zhao China 32 1.0k 1.0× 659 0.9× 340 0.8× 472 1.2× 91 0.2× 95 2.7k
Younes Pilehvar‐Soltanahmadi Iran 47 1.6k 1.5× 1.4k 2.1× 286 0.7× 894 2.3× 248 0.7× 86 3.9k
Mohamed Benderdour Canada 37 1.7k 1.6× 459 0.7× 298 0.7× 303 0.8× 90 0.2× 87 3.9k
Yijie Shi China 33 1.6k 1.5× 519 0.7× 164 0.4× 421 1.1× 395 1.1× 70 3.1k
Yao Fu China 36 1.9k 1.8× 1.1k 1.6× 378 0.9× 866 2.2× 72 0.2× 161 4.2k
Daquan Chen China 35 1.3k 1.2× 961 1.4× 246 0.6× 1.0k 2.7× 65 0.2× 121 3.5k
Shima Tavakol Iran 31 1.1k 1.0× 827 1.2× 164 0.4× 813 2.1× 98 0.3× 84 3.0k
Longfa Kou China 37 1.5k 1.4× 1.2k 1.7× 491 1.2× 983 2.5× 98 0.3× 109 4.0k
Xue Yang China 30 1.3k 1.3× 333 0.5× 408 1.0× 688 1.8× 86 0.2× 156 3.2k

Countries citing papers authored by Xianhuo Wang

Since Specialization
Citations

This map shows the geographic impact of Xianhuo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianhuo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianhuo Wang more than expected).

Fields of papers citing papers by Xianhuo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianhuo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianhuo Wang. The network helps show where Xianhuo Wang may publish in the future.

Co-authorship network of co-authors of Xianhuo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xianhuo Wang. A scholar is included among the top collaborators of Xianhuo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianhuo Wang. Xianhuo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sun, Cong, et al.. (2025). Molecular landscape of distinct follicular lymphoma histologic grades: Insights from genomic and transcriptome analyses.. Journal of Clinical Oncology. 43(16_suppl). 7002–7002. 1 indexed citations
3.
Wang, Xianhuo, et al.. (2024). CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma. Cancer Research. 84(13). 2123–2140. 12 indexed citations
4.
5.
Zhao, Jing, Yunhui Hu, Shiyong Zhou, et al.. (2024). Evaluation of the anti-breast cancer properties of Origanum majorana aqueous extract green-mediated nanoparticles. Inorganic Chemistry Communications. 169. 113098–113098. 1 indexed citations
6.
Liu, Hao, et al.. (2023). M6A‐REGULATOR EXPRESSION SIGNATURES IDENTIFY A SUBSET OF FOLLICULAR LYMPHOMA HARBORING AN EXHAUSTED TUMOR MICROENVIRONMENT. Hematological Oncology. 41(S2). 630–630. 1 indexed citations
7.
Li, Yang, Chengfeng Bi, Lanfang Li, et al.. (2023). OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma. Clinical Immunology. 251. 109637–109637. 7 indexed citations
8.
Ren, Weicheng, Hui Wan, Mattias Berglund, et al.. (2023). Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia. 38(3). 610–620. 9 indexed citations
9.
Li, Lanfang, Lihua Qiu, Zhengzi Qian, et al.. (2023). CD58 Genetic Alterations and Its Contribution to Upregulation of PD-L1 and IDO Via LYN/CD22/SHP1 Axis in DLBCL. Blood. 142(Supplement 1). 524–524. 2 indexed citations
10.
Wang, Xiaoxuan, Xiaoxuan Wang, Wenchen Gong, et al.. (2022). A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma. Clinical Immunology. 243. 109105–109105. 16 indexed citations
11.
Wang, Xianhuo, Yue Fei, Lanfang Li, et al.. (2021). Biological and Clinical Significance of PIM1 Genetic Alterations in Diffuse Large B-Cell Lymphoma. Blood. 138(Supplement 1). 3494–3494. 1 indexed citations
12.
Ye, Xiaofei, Weicheng Ren, Dongbing Liu, et al.. (2020). Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas. The Journal of Experimental Medicine. 218(2). 24 indexed citations
13.
Wang, Xianhuo, Tingting Zhang, Zheng Song, et al.. (2019). Tumor CD73/A2aR adenosine immunosuppressive axis and tumor‐infiltrating lymphocytes in diffuse large B‐cell lymphoma: correlations with clinicopathological characteristics and clinical outcome. International Journal of Cancer. 145(5). 1414–1422. 27 indexed citations
14.
Lang, Mingxiao, Jingwei Yu, Xianhuo Wang, et al.. (2018). Immunochemotherapeutic increase of peripheral absolute monocyte count predicts interstitial pneumonia in lymphoma patients. Hematological Oncology. 36(5). 779–785. 3 indexed citations
15.
Zhang, Huilai, Ling Dong, Qingqing Chen, et al.. (2017). Synergistic antitumor effect of histone deacetylase inhibitor and Doxorubicin in peripheral T-cell lymphoma. Leukemia Research. 56. 29–35. 32 indexed citations
16.
Wang, Xianhuo, Huaqing Wang, Chengfeng Bi, et al.. (2015). Microrna-17~92 Cluster Upregulates NF-KB Activity Via Suppressing Multiple NF-KB Negative Regulators Mediating Ubiquitination. Blood. 126(23). 3638–3638. 1 indexed citations
17.
Wang, Xianhuo, et al.. (2010). Clinical Pharmacokinetics of Paclitaxel Liposome with a New Route of Administration in Human Based on the Analysis with Ultra Performance Liquid Chromatography. Journal of Pharmaceutical Sciences. 99(11). 4746–4752. 11 indexed citations
18.
Wang, Xianhuo, et al.. (2010). A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions. European Journal of Cancer. 46(8). 1474–1480. 54 indexed citations
19.
Zhao, Bing, et al.. (2008). Agrobacterium rhizogenes-mediated Transformation and Regeneration of the Apocynum venetum. Chinese journal of biotechnology/Shengwu gongcheng xuebao. 24(10). 1723–1728. 12 indexed citations
20.
Wang, Chi Chiu, et al.. (2007). Pingyangmycin loaded bovine serum albumin microspheres for chemoembolization therapy—in vitro and in vivo studies. International Journal of Pharmaceutics. 351(1-2). 219–226. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehdi Dadashpour Breakdown of academic impact, for papers by Ling Zhao Breakdown of academic impact, for papers by Younes Pilehvar‐Soltanahmadi Breakdown of academic impact, for papers by Mohamed Benderdour Breakdown of academic impact, for papers by Yijie Shi Breakdown of academic impact, for papers by Yao Fu Breakdown of academic impact, for papers by Daquan Chen Breakdown of academic impact, for papers by Shima Tavakol Breakdown of academic impact, for papers by Longfa Kou Breakdown of academic impact, for papers by Xue Yang
Rankless by CCL
2026